Get the Stockscreener App
23.92
1.12%
-0.27
After Hours:
24.49
0.57
+2.38%
Innoviva Inc stock is traded at $23.92, with a volume of 515.38K.
It is down -1.12% in the last 24 hours and up +8.58% over the past month.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
See More
Previous Close:
$24.19
Open:
$24.17
24h Volume:
515.38K
Relative Volume:
0.68
Market Cap:
$1.77B
Revenue:
$425.13M
Net Income/Loss:
$271.17M
P/E Ratio:
7.829
EPS:
3.0553
Net Cash Flow:
$195.80M
1W Performance:
+1.27%
1M Performance:
+8.58%
6M Performance:
+37.55%
1Y Performance:
+32.08%
1-Day Range:
$23.73
$24.30
1-Week Range:
$23.39
$24.45
52-Week Range:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
23.92 | 1.79B | 425.13M | 271.17M | 195.80M | 3.0553 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Initiated | BTIG Research | Buy |
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
AI Stocks: Will Innoviva Inc stock hit new highs in YEAR2026 Risk Factors & Verified Short-Term Trading Plans - baoquankhu1.vn
Trade Recap: Will Innoviva Inc outperform tech stocks2026 Retail Activity & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Earnings Recap: Will Innoviva Inc benefit from sector rotation2026 Geopolitical Influence & Technical Entry and Exit Tips - baoquankhu1.vn
INVA Technical Analysis & Stock Price Forecast - Intellectia AI
(INVA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Aug Summary: Is Innoviva Inc likely to announce a buyback2026 Technicals & Fast Entry and Exit Trade Plans - baoquankhu1.vn
3 Bargain-Cheap Small Caps Worth a Second Look - Investing.com
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo Finance
Buybacks Report: Is Innoviva Inc likely to announce a buybackProfit Target & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Cantor Fitzgerald reiterates Innoviva stock rating on royalty strength - Investing.com
Innoviva Stock Crosses 200-Day Moving Average - National Today
Innoviva (NASDAQ:INVA) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Profit Recap: Will Innoviva Inc stock hit new highs in YEAR2026 PostEarnings & Entry Point Strategy Guides - baoquankhu1.vn
S P Trends: Will Innoviva Inc outperform tech stocks2026 Support & Resistance & Free Verified High Yield Trade Plans - baoquankhu1.vn
Innoviva, Inc. (INVA) Stock forecasts - Yahoo Finance UK
INVA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Innoviva Inc (NASDAQ:INVA) Screened as a Top Value Stock with Strong Fundamentals - ChartMill
Innoviva Inc (HVE.SG) Stock Forum & Discussion - Yahoo! Finance Canada
Innoviva Inc (HVE.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Innoviva, Inc. (INVA) stock price, news, quote and history - Yahoo Finance UK
INVA Stock Price, Quote & Chart | INNOVIVA INC (NASDAQ:INVA) - ChartMill
INVA PE Ratio & Valuation, Is INVA Overvalued - Intellectia AI
Earnings Report: Is Innoviva Inc likely to announce a buyback2026 Sector Moves & Verified Chart Pattern Signals - baoquankhu1.vn
Aug Levels: Will Innoviva Inc stock hit new highs in YEAR2026 Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
Price-Driven Insight from (INVA) for Rule-Based Strategy - Stock Traders Daily
Working capital per share of Innoviva, Inc. – BX:HVE - TradingView
Book value per share of Innoviva, Inc. – BX:HVE - TradingView
Aug Mood: Should I invest in Innoviva Inc before earningsDollar Strength & Daily Entry Point Trade Alerts - baoquankhu1.vn
Net current asset value per share of Innoviva, Inc. – BX:HVE - TradingView
INVA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Innoviva (INVA) files 10-K/A adding Armata audited financials and new officer certifications - Stock Titan
Vanguard discloses 0% Innoviva holding (NASDAQ: INVA) - Stock Titan
INNOVIVA PB Ratio: 1.44 — 30% Below Median - GuruFocus
Risk Recap: What is the next catalyst for Innoviva IncBuy Signal & Daily Oversold Bounce Ideas - baoquankhu1.vn
Armata Pharmaceuticals (NASDAQ: ARMP) advances late-stage phage pipeline with new funding - Stock Titan
Retail Trends: Is Innoviva Inc impacted by rising rates2026 Rallies & AI Enhanced Execution Alerts - baoquankhu1.vn
Innoviva (NASDAQ: INVA) ties big 2026 equity plan to strong 2025 results - Stock Titan
Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of "Moderate Buy" from Analysts - marketbeat.com
Is It Time To Revisit Innoviva (INVA) After Strong Multi Year Share Price Gains - Yahoo Finance
Oliver Luxxe Assets LLC Invests $1.69 Million in Innoviva - National Today
Oliver Luxxe Assets LLC Makes New $1.69 Million Investment in Innoviva, Inc. $INVA - MarketBeat
Aug Levels: Is Innoviva Inc likely to announce a buybackWeekly Stock Recap & Consistent Profit Trade Alerts - baoquankhu1.vn
Innoviva spotlights subgroup analysis from ATHOS-3 trial on thromboembolic events - Traders Union
Innoviva (NASDAQ:INVA) Stock Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
(INVA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Innoviva, Inc. (INVA): A bull case theory - MSN
Assessing Innoviva (INVA) Valuation After Strong Earnings Growth And Portfolio Expansion - Sahm
Forecast Cut: Whats the RSI of Innoviva Inc stockWeekly Trend Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
How Investors May Respond To Innoviva (INVA) Surging EPS From Continuing Operations - simplywall.st
Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report - Weekly Voice
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):